[GM6001 suppresses scar formation after glaucoma filtration surgery in rabbits]

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Feb;34(2):241-5.
[Article in Chinese]

Abstract

Objective: To study the effect of matrix metalloproteinases inhibitor GM6001 in suppressing scar tissue formation in the filtering passage after glaucoma filtration surgery.

Methods: Twenty-four pigmented rabbits (48 eyes) underwent trabeculectomy followed by subconjunctival injection of GM6001 in the right eye (treated eyes) and injection of PBS in the left eye (control) once a day. The intraocular pressure was monitored postoperatively and proliferating cell nuclear antigen (PCNA)- and α-smooth muscle actin (α-SMA)-positive cells in the filtering pathway were detected using immunohistochemistry.

Results: On postoperative days 7, 14, 21, and 28, the intraocular pressure was significantly lower in the treated eyes (GM6001) than in the control eyes (P<0.01). The counts of PCNA- and α-SMA-positive cells were also significantly lowered in the treated than in the control eyes (P<0.01).

Conclusion: GM6001 can inhibit excessive proliferation of the fibroblasts in the filtering pathway to suppress scar tissue formation and prolong the existence of the functional filtration bleb in rabbits.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Cicatrix / pathology
  • Cicatrix / prevention & control*
  • Dipeptides / pharmacology*
  • Filtering Surgery / adverse effects*
  • Glaucoma / surgery
  • Intraocular Pressure
  • Postoperative Complications*
  • Proliferating Cell Nuclear Antigen / metabolism
  • Rabbits

Substances

  • Actins
  • Dipeptides
  • N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
  • Proliferating Cell Nuclear Antigen